RecruitingNCT03299608

Rapid Analysis of Infections by Spectrometry of Exhaled Breath

Exhaled Breath Analysis for Rapid Diagnosis in Opportunistic Respiratory Infections in Hematological Patients


Sponsor

Universitaire Ziekenhuizen KU Leuven

Enrollment

246 participants

Start Date

Jun 21, 2019

Study Type

OBSERVATIONAL

Conditions

Summary

To quantify the diagnostic, prognostic and therapeutic value of spectrometric analysis of exhaled breath from hematological patients with respiratory infection.


Eligibility

Min Age: 18 Years

Inclusion Criteria10

  • Age ≥ 18y at start of study
  • One of the following diagnoses:
  • De novo, refractory or relapsed AML/MDS receiving intensive chemotherapy
  • De novo, refractory or relapsed ALL/T-lymphoblastic lymphoma receiving intensive chemotherapy
  • Aplastic anemia requiring ATG therapy
  • Any patient admitted for either autologous hematopoietic stem cell transplantation. Transplantation may not have been performed at time of enrolment.
  • Any patient admitted with allogeneic hematopoietic stem cell transplantation within the last year, or planned during this admission.
  • Written informed consent obtained from the patient
  • Signs of active respiratory infection
  • If previously enrolled: incomplete clearance of all signs of respiratory infection (both clinically, microbiologically and radiologically).

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTBreath analysis

Spectrometric analysis of exhaled breath as screening for opportunistic respiratory infections


Locations(1)

University Hospitals Leuven

Leuven, Belgium

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03299608


Related Trials